Animal Antimicrobials Sales Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Animal Antimicrobials Sales Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Report Code: KNJ554266 | No. of Pages: 98 | Category: Chemicals and Materials
Publisher: 99Strategy | Date of Publish: Nov-2020
Summary

Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.

The global Animal Antimicrobials Sales market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.

Based on the type of product, the global Animal Antimicrobials Sales market segmented into
    Premixes
    Oral Powders
    Oral Solutions
    Injections
    Others

Based on the end-use, the global Animal Antimicrobials Sales market classified into
    Food-producing Animals
    Companion Animals

Based on geography, the global Animal Antimicrobials Sales market segmented into
    North America [U.S., Canada, Mexico]
    Europe [Germany, UK, France, Italy, Rest of Europe]
    Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
    South America [Brazil, Argentina, Rest of Latin America]
    Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]

And the major players included in the report are
    Zoetis, Inc.
    Boehringer Ingelheim GmbH
    Eli Lilly and Company
    Merck & Co., Inc.
    Bayer AG
    Sanofi
    Ceva Sante Animale
    Virbac
    Vetoquinol S.A.
    Dechra Pharmaceuticals PLC
Table of Contents
1  RESEARCH SCOPE
    1.1 Research Product Definition
    1.2 Research Segmentation
        1.2.1 Product Type
        1.2.2 Main product Type of Major Players
    1.3 Demand Overview
    1.4 Research Methodology
2 GLOBAL ANIMAL ANTIMICROBIALS SALES INDUSTRY
    2.1 Summary about Animal Antimicrobials Sales Industry
    2.2 Animal Antimicrobials Sales Market Trends
        2.2.1 Animal Antimicrobials Sales Production & Consumption Trends
        2.2.2 Animal Antimicrobials Sales Demand Structure Trends
    2.3 Animal Antimicrobials Sales Cost & Price
3  MARKET DYNAMICS
    3.1 Manufacturing & Purchasing Behavior in 2020
    3.2 Market Development under the Impact of COVID-19
        3.2.1 Drivers
        3.2.2 Restraints
        3.2.3 Opportunity
        3.2.4 Risk
4  GLOBAL MARKET SEGMENTATION
    4.1 Region Segmentation (2017 to 2021f)
        4.1.1 North America (U.S., Canada and Mexico)
        4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
        4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
        4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
        4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
    4.2 Product Type Segmentation (2017 to 2021f)
        4.2.1 Premixes
        4.2.2 Oral Powders
        4.2.3 Oral Solutions
        4.2.4 Injections
        4.2.5 Others
    4.3 Consumption Segmentation (2017 to 2021f)
        4.3.1 Food-producing Animals
        4.3.2 Companion Animals
5  NORTH AMERICA MARKET SEGMENT
    5.1 Region Segmentation (2017 to 2021f)
        5.1.1 U.S.
        5.1.2 Canada
        5.1.3 Mexico
    5.2 Product Type Segmentation (2017 to 2021f)
        5.2.1 Premixes
        5.2.2 Oral Powders
        5.2.3 Oral Solutions
        5.2.4 Injections
        5.2.5 Others
    5.3 Consumption Segmentation (2017 to 2021f)
        5.3.1 Food-producing Animals
        5.3.2 Companion Animals
    5.4 Impact of COVID-19 in North America
6  EUROPE MARKET SEGMENTATION
    6.1 Region Segmentation (2017 to 2021f)
        6.1.1 Germany
        6.1.2 UK
        6.1.3 France
        6.1.4 Italy
        6.1.5 Rest of Europe
    6.2 Product Type Segmentation (2017 to 2021f)
        6.2.1 Premixes
        6.2.2 Oral Powders
        6.2.3 Oral Solutions
        6.2.4 Injections
        6.2.5 Others
    6.3 Consumption Segmentation (2017 to 2021f)
        6.3.1 Food-producing Animals
        6.3.2 Companion Animals
    6.4  Impact of COVID-19 in Europe
7  ASIA-PACIFIC MARKET SEGMENTATION
    7.1 Region Segmentation (2017 to 2021f)
        7.1.1 China
        7.1.2 India
        7.1.3 Japan
        7.1.4 South Korea
        7.1.5 Southeast Asia
        7.1.6 Australia
        7.1.7 Rest of Asia Pacific
    7.2 Product Type Segmentation (2017 to 2021f)
        7.2.1 Premixes
        7.2.2 Oral Powders
        7.2.3 Oral Solutions
        7.2.4 Injections
        7.2.5 Others
    7.3 Consumption Segmentation (2017 to 2021f)
        7.3.1 Food-producing Animals
        7.3.2 Companion Animals
    7.4  Impact of COVID-19 in Europe
8  SOUTH AMERICA MARKET SEGMENTATION
    8.1 Region Segmentation (2017 to 2021f)
        8.1.1 Brazil
        8.1.2 Argentina
        8.1.3 Rest of Latin America
    8.2 Product Type Segmentation (2017 to 2021f)
        8.2.1 Premixes
        8.2.2 Oral Powders
        8.2.3 Oral Solutions
        8.2.4 Injections
        8.2.5 Others
    8.3 Consumption Segmentation (2017 to 2021f)
        8.3.1 Food-producing Animals
        8.3.2 Companion Animals
    8.4  Impact of COVID-19 in Europe
9  MIDDLE EAST AND AFRICA MARKET SEGMENTATION
    9.1 Region Segmentation (2017 to 2021f)
        9.1.1 GCC
        9.1.2 North Africa
        9.1.3 South Africa
        9.1.4 Rest of Middle East and Africa
    9.2 Product Type Segmentation (2017 to 2021f)
        9.2.1 Premixes
        9.2.2 Oral Powders
        9.2.3 Oral Solutions
        9.2.4 Injections
        9.2.5 Others
    9.3 Consumption Segmentation (2017 to 2021f)
        9.3.1 Food-producing Animals
        9.3.2 Companion Animals
    9.4  Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
    10.1 Brief Introduction of Major Players
        10.1.1 Zoetis, Inc.
        10.1.2 Boehringer Ingelheim GmbH
        10.1.3 Eli Lilly and Company
        10.1.4 Merck & Co., Inc.
        10.1.5 Bayer AG
        10.1.6 Sanofi
        10.1.7 Ceva Sante Animale
        10.1.8 Virbac
        10.1.9 Vetoquinol S.A.
        10.1.10 Dechra Pharmaceuticals PLC
    10.2  Animal Antimicrobials Sales Sales Date of Major Players (2017-2020e)
        10.2.1 Zoetis, Inc.
        10.2.2 Boehringer Ingelheim GmbH
        10.2.3 Eli Lilly and Company
        10.2.4 Merck & Co., Inc.
        10.2.5 Bayer AG
        10.2.6 Sanofi
        10.2.7 Ceva Sante Animale
        10.2.8 Virbac
        10.2.9 Vetoquinol S.A.
        10.2.10 Dechra Pharmaceuticals PLC
    10.3  Market Distribution of Major Players
    10.4 Global Competition Segmentation
11  MARKET FORECAST
    11.1  Forecast by Region
    11.2  Forecast by Demand
    11.3  Environment Forecast
        11.3.1  Impact of COVID-19
        11.3.2  Geopolitics Overview
        11.3.3  Economic Overview of Major Countries
12  REPORT SUMMARY STATEMENT

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com